Projects funded by the NCN
Histone demethylase inhibitors as chemosensitivity modulators in the treatment of head and neck squamous cell carcinoma
2022/45/N/NZ7/01780
Keywords:
Histone demethylase inhibitors KDM4 KDM5 KDM6 head and neck cancer HNSCC cancer stem cells CSC cisplatin erlotinib chemoresistance spheroids
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
- NZ5_7: Human disease treatment
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu
woj. wielkopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 2
Call: PRELUDIUM 21 - announced on 2022-03-28
Amount awarded: 209 960 PLN
Project start date (Y-m-d): 2023-01-25
Project end date (Y-m-d): 2026-01-24
Project duration:: 36 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.